Ophthalmic Case Studies and Novel Approach

In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    August 07-08, 2020

    4th International Conference on Ophthalmology

    Osaka, Japan
    August 24-25, 2020

    World Congress on Ophthalmology & Optometry

    London, UK
    August 24-25, 2020

    34th Global Ophthalmologists Annual meeting

    London, UK
    September 28-29, 2020

    4th Annual Conference on Orthopedics, Rheumatology and Osteoporosis

    Prague, Czech Republic
    October 19-20, 2020

    19th Asia Pacific Ophthalmologists Annual Meeting

    Singapore City, Singapore
    October 22-23, 2020

    World Congress on Ophthalmology and Optometry

    Tokyo, Japan
    October 28-29, 2020

    30th World Congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    November 12-13, 2020

    European Conference on Ophthalmology & Eye care

    Budapest, Hungary
    November 23-24, 2020

    3rd World Congress on Eye and Vision

    Istanbul, Turkey
    November 23-24, 2020

    3rd World Eye and Vision Congress

    Istanbul, Turkey
    November 23-24, 2020

    34th European Ophthalmology Congress

    Rome, Italy

    Ophthalmic Case Studies and Novel Approach Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in